TSRI Study Identifies New Type of Protein Clump that May Be Implicated in ALS
The Findings May Lead to New Therapies for ALS and Other Neurodegenerative Conditions
“We have uncovered a new molecular mechanism underlying neurodegeneration,” said Claudio Joazeiro, associate professor of cell and molecular biology at The Scripps Research Institute (TSRI) and senior author of the new study. “This could lead to new diagnostics or new therapeutic approaches, especially for ALS.” This new mechanism, or specific enzyme, can “tag” certain types of proteins to send them to join clumps. These clumps protect against neurodegenerative disease such as ALS, or Lou Gehrig’s disease. These findings provide a new perspective on the role of protein clumps that have previously been associated with some types of neurological disease. Click here to read more.
Intraoperative Neurophysiology in Neurosurgery: The Essentials. 2nd Edition
Dec. 14-16, 2017; Verona, Italy
Mayo Clinic Neuroscience and Oncology Innovation Summit 2017
Dec. 14, 2017 - Dec. 16, 2017; Orlando, Fla.
43rd Annual Meeting of Louisiana Neurosurgical Society
Jan. 12, 2018 - Jan. 13, 2018; Shreveport, La.
2018 CANS Annual Meeting
Jan. 12-14, 2018; San Diego